Physician
Twin Pediatrics, P.C.
Twin Pediatrics, P.C. was paid $4.78M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoTWIN PEDIATRICS, P.C.
PHOENIX, AZ 85020
PHOENIX, AZ 85020
33aNPI1568675908assigned 05/08/2007
33bProvider typePediatrics Physician
28Total paid$4.78M
24GClaims112,042
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Arizona
Rank by total paid#22 of 235
Median peer was paid$164K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,056 | $851K | |
| 2019 | 23,505 | $840K | |
| 2020 | 16,663 | $623K | |
| 2021 | 15,322 | $722K | |
| 2022 | 13,737 | $745K | |
| 2023 | 11,298 | $599K | |
| 2024incomplete | 7,461 | $402K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 34,458 | 29,373 | $1.85M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 11,129 | 10,464 | $859K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.9% | 5,880 | 5,050 | $426K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.8% | 12,658 | 12,157 | $419K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.7% | 4,630 | 4,523 | $367K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.1% | 4,358 | 4,199 | $338K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.9% | 3,778 | 3,686 | $328K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 1,914 | 1,782 | $55K |
| 99381 | <1% | 428 | 421 | $36K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,125 | 2,022 | $34K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 725 | 691 | $17K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 720 | 666 | $10K |
32 more codes
| 99460 | <1% | 140 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 603 | $8K |
| 86580 | <1% | 850 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 73 | $4K |
| 99173 | <1% | 4,571 | $4K | |
| 99383 | <1% | 40 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 242 | $3K |
| 96127 | <1% | 364 | $2K | |
| 94760 | <1% | 1,229 | $2K | |
| 99188 | <1% | 95 | $1K | |
| 90473 | <1% | 59 | $873.75 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 851 | $850.61 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 34 | $753.44 |
| 90670 | <1% | 3,360 | $239.51 | |
| 81002 | <1% | 58 | $141.30 | |
| 90698 | <1% | 3,306 | $111.21 | |
| 90672 | <1% | 209 | $105.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 441 | $47.47 |
| 90619 | <1% | 274 | $15.43 | |
| 90686 | <1% | 2,813 | $10.43 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 228 | $8.63 |
| 90680 | <1% | 1,940 | $7.91 | |
| 90710 | 0% | 1,417 | $0.00 | |
| 90715 | 0% | 537 | $0.00 | |
| 90633 | 0% | 1,179 | $0.00 | |
| 90685 | 0% | 286 | $0.00 | |
| 90734 | 0% | 755 | $0.00 | |
| 90651 | 0% | 1,167 | $0.00 | |
| 90744 | 0% | 1,565 | $0.00 | |
| 90620 | 0% | 250 | $0.00 | |
| 90696 | 0% | 260 | $0.00 | |
| 90656 | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUMAPLIN, LUDWIG (PRESIDENT)